A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold
Clinical trial NCT06697886 · RECRUITING
Trial details
- NCT number
- NCT06697886
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-16
- Primary completion
- 2025-06-25
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.